InvestorsHub Logo
Followers 65
Posts 3808
Boards Moderated 0
Alias Born 03/26/2016

Re: None

Friday, 10/04/2019 3:16:16 PM

Friday, October 04, 2019 3:16:16 PM

Post# of 409
mnk should be o k if they don`t throw in with the rest of the other bio`s that are considering B K OVER THE OPIOD CRISIS.

they have about 15 drugs in trials......a few are at stage 4

they bought ocera (ocrx) about 2 years ago for a liver drug....it was ocr-002 an ammonia scavenger....mnk renamed it MNK6106...finishing trial for hepatic cirrhosis...study end oct 30/19.....data to follow .......this could be a nice bail-out for them, if positive data........MNK was about $40/share last year

I sold a bunch of ocrx for the offer, but kept about 8000 with mnk for the milestone payments......volume is low....most traders are afraid of what other states might file against the pill pushers.......risk is high, but bargain price for this company

$$$$$$$$$$$$$$$$$$$$$ MNK $$$$$$$$$$$$$$$....glta

don`t listen to me, don`t have a clue!

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.